The Thrive Study: Improving Multimodal Physical Function in Adults With Heterogenous Chronic Pain
CompletedNot applicableNCT05700383
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The investigators aim to conduct a randomized controlled trial to test the feasibility of a mind-body walking program compared to a health education program for individuals with chronic musculoskeletal pain. The investigators will assess the feasibility of recruitment procedures (enrollment, recruitment of racial and ethnic minorities) and intervention delivery (fidelity, adherence, credibility, satisfaction, optimization), following pre-specified benchmarks. Both programs will be delivered in-person.
Study details
- Official title
- The Thrive Study: Improving Multimodal Physical Function in Adults With Heterogenous Chronic Pain: Multi-site Feasibility RCT
- Conditions
- Interventions
- Behavioral: GetActive-Fitbit
- Behavioral: Healthy Living for Pain
- Sponsor
- Massachusetts General Hospital
- Collaborators
- Rush University Medical Center; Duke University; National Center for Complementary and Integrative Health (NCCIH)
- Start date
- 2023-04-01
- Primary completion
- 2024-10-01
- Sex
- All
- Age range
- from 18 Years
- Healthy volunteers
- true
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 3
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Male and female outpatients, age 18 years or older 2. Fluent in English 3. Have nonmalignant chronic musculoskeletal pain for more than 3 months 4. Able to perform a 6-minute walk test (6MWT) 5. Owns a smartphone with Bluetooth 4.0 or computer 6. Willingness and ability to participate in one of the 2 programs and to comply with the requirements of the study protocol. 7. Free of concurrent psychotropic medication for at least 2 weeks prior to initiation of treatment, OR stable on current medication for a minimum of 6 weeks and willing to maintain a stable dose 8. Low-level of activity (must meet 2/3 criteria; if difficult to assess, recruiter may ask participant to report their recent step data from their smartphone to better understand their activity level) 1. Sitting for more than 8 hours/day per self-report 2. Exercising for fewer than 3 days/week (30+min of exercise constitutes an "exercise day") per self-report 3. Walking for fewer than 7 days/week (30+min of walking constitutes a "walking day") per self-report Exclusion Criteria: 1. Diagnosed with a medical illness expected to worsen in the next 6 months (e.g., malignancy) 2. Serious mental illness or instability for which hospitalization may be likely in the next 6 months 3. Current active suicidal ideation reported on self-report 4. Untreated and/or unstable schizophrenia, bipolar disorder, or other psychotic disorder 5. Current, active substance abuse or dependence, and current alcohol dependence within the past 6 months 6. Practice of yoga, meditation, guided imagery or other mind body techniques that elicit the RR, once per week for \>45 min 3 times/week within the last 3 months or less. 7. Regular use of Fitbit DMD in the last 3 months 8. Unable to walk/in a wheelchair 9. Mild cognitive decline for participants 65+ only (Short Portable Mental Status Questionnaire; PMSQ 4 or more errors).
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05700383